Predictive Value of Myelodysplastic Syndrome Stem Cells Determined by Multiparameter Flow Cytometry
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.
- Status
- RECRUITING
- Phase
- PHASE2
Phase I Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT
- Status
- RECRUITING
- Phase
- PHASE1
VA Combined With PD-1 Inhibitor for the Treatment of Relapsed and Refractory AML and High-risk MDS
- Status
- RECRUITING
- Phase
- PHASE2
Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen
- Status
- RECRUITING
- Phase
- PHASE2
Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE2
Vitamin A and D Supplementation in Allogeneic HCT
- Status
- RECRUITING
- Phase
- PHASE2
Iadademstat With Hypomethylating Agent in Patients With Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- PHASE1
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- Status
- RECRUITING
- Phase
- PHASE3
HEME Home Transfusion Program
- Status
- RECRUITING
- Phase
- NA
BeFluBu vs FluBuRux Conditioning in Haploidentical HCT
- Status
- RECRUITING
- Phase
- PHASE2
Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Children and Young Adults With Hemoblastosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
A Study to Investigate 14C-bemcentinib in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the MNV-201 in Patients With Low Risk MDS
- Status
- RECRUITING
- Phase
- PHASE1
ACHIEVE2 - Safety and Preliminary Efficacy of Intravenous TCB008 in Patients With Relapse or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)/AML
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- Status
- RECRUITING
- Phase
- PHASE1
Biological, Prospective Study Evaluating the Dosage of Plasma Cytokines Including the FLT3 Ligand and IL6 of Patients Treated With Non-intensive Chemotherapy
- Status
- RECRUITING
- Phase
- N/A
Unified platforM for a Better integRal Evaluation of MyeLodyspLastic Syndromes in SpAin-Strategy for Unraveling Personalized genoMic Medicine in Public heAlth System (UMBRELLA-SUMMA)
- Status
- RECRUITING
- Phase
- N/A
A Study of GLB-001 in Patients With Myeloid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1